CD274 and radiation pneumonitis: Recently, consolidation treatment with human monoclonal antibodies against programmed cell death-ligand 1 (PD-L1) has been recommended in patients without disease progression and symptomatic radiation pneumonitis after chemoradiotherapy [7–9].